Author:
Winter-Roach B.,Hooper L.,Kitchener H.
Abstract
A systematic review and meta analysis has been undertaken in order to evaluate the effectiveness of adjuvant therapy following surgery for early ovarian cancer. Trials reported since 1990 have been of a higher quality enabling a meta analysis of adjuvant chemotherapy vs adjuvant radiotherapy and a meta analysis of adjuvant chemotherapy vs observation. There was no significant difference between radiotherapy and chemotherapy, though these comprised studies which demonstrated considerable heterogeneity. Chemotherapy did confer significant benefit over observation in terms of both overall and disease free survival. Except for women in whom adequate surgical staging has revealed well differentiated disease confined to one or both ovaries with intact capsule, platinum chemotherapy should be offered to reduce risk of recurrence.
Subject
Obstetrics and Gynaecology,Oncology
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of radiotherapy in ovarian cancer;International Journal of Gynecologic Cancer;2022-03
2. Epithelial Ovarian Cancer;Contemporary Obstetrics and Gynecology for Developing Countries;2021
3. Ovarian Cancer, Early Primary Disease;Practical Medical Oncology Textbook;2021
4. Cancers gynécologiques;Pharmacie Clinique Pratique en Oncologie;2020
5. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2015-12-17